1. Home
  2. Analysis
  3. Aurovela-1-5-30

Aurovela 1.5/30 side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Aurovela 1.5/30. Common side effects include abdominal discomfort among females.

The phase IV clinical study is created by eHealthMe based on 12 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 19, 2023

12 people who take Aurovela 1.5/30 and have side effects are studied.

What is Aurovela 1.5/30?

Aurovela 1.5/30 has active ingredients of ethinyl estradiol; norethindrone acetate. Currently, eHealthMe is studying from 15 Aurovela 1.5/30 users.

Number of Aurovela 1.5/30 reports submitted per year:

Aurovela 1.5/30 side effects.

Aurovela 1.5/30 side effects by gender *:

female:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Drug ineffective
  4. Injection site reaction
  5. Loss of consciousness
  6. Oral herpes (viral infection of mouth)

male:

n/a

Aurovela 1.5/30 side effects by age (0-1 to 60+) *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Injection site reaction

20-29:

  1. Loss of consciousness

30-39:

  1. Abdominal distension
  2. Drug ineffective
  3. Oral herpes (viral infection of mouth)

40-49:

n/a

50-59:

n/a

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Aurovela 1.5/30?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

How the study uses the data?

The study is based on ethinyl estradiol; norethindrone acetate (the active ingredients of Aurovela 1.5/30) and Aurovela 1.5/30 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Aurovela 1.5/30:

All Aurovela 1.5/30 side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.